News Article,Video

Maple Grove Medical Device Company Pioneers New Treatment For Prostate Cancer

June 18, 2020

Francis Medical Research Team

CCX Media visited Francis Medical, Wednesday, June 17, 2020 for exclusive interviews with CEO and President, Mike Kujak, and Founder and CTO, Michael Hoey.

Their two-minute video includes an explanation of our revolutionary water vapor therapy, as well as plans for the future, including our VAPOR 1 clinical study.

Click for Full Article

Share this post

Recent Posts

Francis Medical Announces Strategic Financing to Accelerate Commercial Expansion and Complete Prostate Cancer Management Indication PMA Program

November 10th, 2026|

MAPLE GROVE, Minn., November 10, 2026 – Francis Medical, Inc., a medical device company dedicated to advancing minimally invasive therapies for urological cancers, today announced that it has entered into an agreement for financing led by Johnson & Johnson through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (JJDC).

  • Dr. Samir Taneja and Northwell Urology team celebrate first commercial Vanquish Water Vapor Ablation procedure in New York
Francis Medical Announces Northwell Urology Group Performs First Commercial Vanquish® Water Vapor Ablation Procedure in New York

August 5th, 2026|

LAKE SUCCESS, NY, August 5, 2026, - Samir S. Taneja, MD, a urologic oncologist, chairman of the Department of Urology at Northwell Health and professor of urology at the Donald and Barbara Zucker School of Medicine, has performed the first commercial Vanquish® Water Vapor Ablation (Vanquish System) procedure in New York state, marking a significant milestone for patients in the region seeking a minimally invasive prostate care option.

  • Dr. Su
Francis Medical Announces Orange County Urology Associates Becomes First in California to Integrate Vanquish® Water Vapor Ablation into Routine Prostate Care

July 7th, 2026|

Maple Grove, Minn., July 7th, 2026 – Daniel Su, MD, a urologist at Orange County Urology Associates (OCUA), has performed the first commercial Vanquish® Water Vapor Ablation procedures in the state of California, offering patients a new minimally invasive Focal Therapy option as part of the group’s prostate care service. The procedure was completed within a single outpatient visit and did not require a hospital stay. Beyond the clinical milestone, Dr. Su’s experience highlights something equally important: how this technology can be adopted into an existing urology practice.